The gap in skin cancer screening rates among patients with psoriasis: A cohort study.

To the Editor: Despite research showing increased risk of skin cancer in patients with psoriasis, there are no studies examining the frequency of skin cancer screening in this population. 1 Butrón-Bris B. Daudén E. Rodríguez-Jiménez P. Psoriasis therapy and skin cancer: a review. Life. 2021; 11: 1109https://doi.org/10.3390/life11101109 Crossref Scopus (7) Google Scholar ,2 Chiesa Fuxench Z.C. Shin D.B. Ogdie Beatty A. Gelfand J.M. The risk of cancer in patients with psoriasis: A population-based cohort study in the health improvement network. JAMA Dermatol. 2016; 152: 282-290https://doi.org/10.1001/jamadermatol.2015.4847 Crossref PubMed Scopus (109) Google Scholar Systemic immunosuppressive and immunomodulatory therapies are increasingly used to treat psoriasis and have been associated with increased risk of skin cancer. 3 Peleva E. Exton L.S. Kelley K. et al. Risk of cancer in patients with psoriasis on biological therapies: a systematic review. Br J Dermatol. 2018; 178: 103-113https://doi.org/10.1111/bjd.15830 Crossref PubMed Scopus (85) Google Scholar We examined skin cancer screening frequency among patients with psoriasis at a tertiary academic medical center.